Kazuo Fujihara, MD, PhD, Fukushima Medical University School of Medicine, Fukishima, Japan, gives an overview of the topics highlighted during a session on hot topics in neuromyelitis optica spectrum disorder (NMOSD). Experts discussed the involvement of B-cells in NMOSD, the available treatments, and how treatment changed with the introduction of treatments supported by randomized placebo-controlled trials. The debate on stopping or de-escalating immune suppressive treatments in NMOSD was a highlight of the session. This interview took place at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress 2022 in Amsterdam, The Netherlands.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved